4.7 Article

Case-cohort study of plasma phospholipid fatty acid profiles, cognitive function, and risk of dementia: a secondary analysis in the Ginkgo Evaluation of Memory Study

期刊

AMERICAN JOURNAL OF CLINICAL NUTRITION
卷 114, 期 1, 页码 154-162

出版社

ELSEVIER SCIENCE INC
DOI: 10.1093/ajcn/nqab087

关键词

Alzheimer disease; fatty acids; cognition; dementia; epidemiology

资金

  1. BrightFocus Foundation [A2017290S]
  2. National Center for Complementary and Alternative Medicine [U01AT000162]
  3. National Institute on Neurological Disorders and Stroke [R01NS089638]
  4. Office of Dietary Supplements of the National Institute on Aging
  5. National Heart, Lung, and Blood Institute
  6. University of Pittsburgh Alzheimer's Disease Research Center [P50AG05133]
  7. Roena Kulynych Center for Memory and Cognition Research
  8. Wake Forest University School of Medicine
  9. National Institute on Aging [K01 AG 066817, K24 AG 065525, U24 AG21886]

向作者/读者索取更多资源

The study found that replacing saturated fatty acids with linoleic acid is associated with a higher risk of dementia and poorer cognitive function, while replacing marine n-3 PUFA DHA with linoleic acid is associated with a lower risk of dementia. These associations were not influenced by factors such as genetics, cognitive impairment, age, or gender.
Background: Phospholipids are biomarkers of dietary fat intake and metabolism. linked to several cardiometabolic disorders. Few prospective studies have assessed plasma phospholipids in relation to dementia risk and cognitive function. Objectives: We aimed to evaluate the association between a decrease in linoleic acid accompanied with an increase in other fatty acids and cognitive function and dementia risk. Methods: We conducted a case-cohort study nested within the Ginkgo Evaluation of Memory Study. We included 1252 participants. 498 of whom who developed dementia during a mean of 5 y of follow-up. We measured 45 individual plasma phospholipids (as a percentage of total plasma phospholipid fatty acids) by GC and related these to Modified Mini-Mental State Examination (3MSE) scores at baseline and neurologist-adjudicated incidence of all-cause dementia and Alzheimer disease (AD). adjusting for sociodemographic and clinical characteristics. Results: Substitution of 1% of SFAs for 1% of linoleic acid, the predominant polyunsaturated n-6 (omega-6) fatty acid, was associated with higher risk of dementia (HR per 1% of SFAs instead of linoleic acid = 1.03; 95% CI: 1.00, 1.07) and a 0.08 point lower 3MSE score at baseline (95% CI: -0.12, -0.03), signifying worse cognitive function. When compared with linoleic acid, we found no associations of total monounsaturated, n-3 polyunsaturated, or trans fatty acids with risk of dementia or AD. However, the substitution of 1% of the marine n-3 PUFA DHA for linoleic acid was associated with lower risk of dementia (HR = 0.86 per 1% of DHA instead of linoleic acid; 95% CI: 0.76, 0.96). These associations were not modified by apolipoprotein E genotype. mild cognitive impairment at baseline, age, or sex. Conclusions: Specific elements of diet may be associated with late-life dementia, a hypothesis that requires formal testing in randomized controlled trials and that represents a possible preventive intervention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据